Quantbot Technologies
SURF

Quantbot Technologies’s Surface Oncology, Inc. Common Stock SURF Stock Holding History

Quantbot Technologies’s Portfolio SURF Stock Details SURF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-3,301
Closed -$3K – 2229
2022
Q3 		$3K Hold
3,301
– – ﹤0.01% 1507
2022
Q2 		$5K Buy
+3,301
New +$6.86K ﹤0.01% 1588

Other funds holding SURF

ARK Investment Management
ARK Investment Management St. Petersburg, Florida $15.5B AUM 50.54% 1-Year Est. Return
EcoR1 Capital
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
Atlas Venture Associates IX
Atlas Venture Associates IX Boston, Massachusetts $11.8M AUM 58.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
Nikko Asset Management Americas
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
DAFNA Capital Management
DAFNA Capital Management Los Angeles, California $524M AUM 164.42% 1-Year Est. Return

Quantbot Technologies's SURF Position: Q4 2022 in Review

Quantbot Technologies sold out of Surface Oncology, Inc. Common Stock (SURF) in Q4 2022, closing a stake of 3,301 shares — an estimated $3K sold.

Quantbot Technologies first reported a position in SURF in Q2 2022 and held it in 2 quarters. The position peaked at $5K in Q2 2022. 78 funds tracked by Wall St. Rank hold SURF as of Q4 2022.

  • Quantbot Technologies reported no remaining Surface Oncology, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Quantbot Technologies sold 3,301 Surface Oncology, Inc. Common Stock shares in Q4 2022, an estimated $3K.
  • Quantbot Technologies first reported a position in Surface Oncology, Inc. Common Stock in Q2 2022 and held it in 2 quarters.
  • Quantbot Technologies's Surface Oncology, Inc. Common Stock position peaked at $5K in Q2 2022.
  • 78 funds tracked by Wall St. Rank held Surface Oncology, Inc. Common Stock as of Q4 2022.

Based on Quantbot Technologies's 13F filing for Q4 2022, filed 13 Feb 2023.